PENTACARINAT 300 mg, powder for aerosol and for parenteral use bottle
Active ingredients: Pentamidine isethionate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for aerosol and for parenteral usebottleinhalée;intramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PENTACARINAT 300 mg, poudre pour aérosol et pour usage parentéral
- Pharmaceutical form
- poudre pour aérosol et pour usage parentéral
- Route of administration
- inhalée;intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 300 mg
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 May 1990
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61423246CIP73322891CIP133400933228910Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PENTAMIDINE (ISÉTIONATE DE)poudre | 300 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.